| ID | Sequence | Length | GC content |
|---|---|---|---|
| CCGGCUGCGCGCGCAGCGGUGGUGGUGGCGGCGCGAUCGGCCGGGCUGU… | 3835 nt | 0.4227 | |
| CCGGCUGCGCGCGCAGCGGUGGUGGUGGCGGCGCGAUCGGCCGGGCUGU… | 3817 nt | 0.4236 | |
| GUGUGUGUGGAAGGGAGAGAGCUGUGCGAGCGUGGGGGAGAGUUUUUCG… | 3476 nt | 0.3855 | |
| GUGUGUGUGGAAGGGAGAGAGCUGUGCGAGCGUGGGGGAGAGUGAGUUG… | 3802 nt | 0.3880 | |
| GUGUGUGUGGAAGGGAGAGAGCUGUGCGAGCGUGGGGGAGAGUGAGUUG… | 3592 nt | 0.3870 | |
| CCGGCUGCGCGCGCAGCGGUGGUGGUGGCGGCGCGAUCGGCCGGGCUGU… | 3910 nt | 0.4228 |
The protein encoded by this gene belongs to a small class of the protein tyrosine phosphatase (PTP) family. PTPs are cell signaling molecules that play regulatory roles in a variety of cellular processes. PTPs in this class contain a protein tyrosine phosphatase catalytic domain and a characteristic C-terminal prenylation motif. This PTP has been shown to primarily associate with plasmic and endosomal membrane through its C-terminal prenylation. This PTP was found to interact with the beta-subunit of Rab geranylgeranyltransferase II (beta GGT II), and thus may function as a regulator of GGT II activity. Overexpression of this gene in mammalian cells conferred a transformed phenotype, which suggested its role in tumorigenesis. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 11, 12 and 17. [provided by RefSeq, Aug 2010]
A study in rats demonstrated that the PTP4A2 was significantly downregulated in left ventricular tissues from an ischemic cardiomyopathy model created via coronary artery ligation [Wang et al. DOI:10.1007/s12031-018-1066-6].